| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/28/1994 | EP0617124A1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 09/28/1994 | EP0616812A1 Combination with anti-hormonal compounds and binding molecules for the treatment of cancer |
| 09/28/1994 | EP0616811A1 Cell-free T cell antigen receptor and its clinical utilities |
| 09/28/1994 | EP0616641A1 Humanized b-b10, an anti-il2 receptor antibody |
| 09/28/1994 | EP0616613A1 Fragments of prion proteins |
| 09/28/1994 | EP0616537A1 CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS |
| 09/28/1994 | EP0616536A1 INHIBITING TRANSFORMING GROWTH FACTOR $g(b) TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 09/28/1994 | EP0616533A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 09/28/1994 | EP0563255B1 Hpv39 papillomavirus genome-derived dna sequences, their application to in vitro diagnosis and production of immunogenic compositions |
| 09/28/1994 | EP0489732B1 A uv-induced factor for immunosuppression |
| 09/28/1994 | EP0467998B1 Peptides from retinoblastoma gene products and antibodies thereto |
| 09/28/1994 | EP0408742B1 Method for production and purification of hepatitis b vaccine |
| 09/28/1994 | EP0222835B1 Oral vaccines |
| 09/28/1994 | CN1092812A Vaccines |
| 09/27/1994 | US5350842 Diagnosis and prevention of syphilis |
| 09/27/1994 | US5350840 Diagnosis |
| 09/27/1994 | US5350835 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 09/27/1994 | US5350671 Detection of antibodies that bind hepatitis C |
| 09/27/1994 | US5350575 Infectious bursal disease virus in poultry |
| 09/27/1994 | US5350574 Immunosuppressive agent for preventing organ rejection |
| 09/26/1994 | CA2116640A1 Carcinoembryonic antigen derivatives |
| 09/24/1994 | CA2118675A1 Transport protein gene from the huntington's disease region |
| 09/21/1994 | EP0616031A2 Bovine ovary cell line (FROv) for virus multiplication |
| 09/21/1994 | EP0615758A1 Anti-tumor vaccines |
| 09/21/1994 | EP0420934B1 Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom |
| 09/21/1994 | EP0371017B1 Antibodies against streptococcus |
| 09/21/1994 | CN1092525A Methods of detecting alzheimer's disease |
| 09/21/1994 | CN1092424A Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 09/21/1994 | CN1092413A Tropone-substituted phenyloxazolidinone antibacterial agents |
| 09/20/1994 | US5349066 Bifunctional linking compounds, conjugates and methods for their production |
| 09/20/1994 | US5348876 DNA molecules and codes with polypeptide sequences |
| 09/20/1994 | US5348866 Genes encoding porcine zona pellucida protein PZP-4, expression thereof and contraceptive vaccines comprising expressed (poly) peptides |
| 09/20/1994 | US5348741 Vector for recombinant poxvirus expressing rabies virus glycoprotein |
| 09/20/1994 | US5348740 Tapeworm |
| 09/19/1994 | CA2119175A1 Nucleic acid pharmaceuticals |
| 09/18/1994 | CA2106740A1 Treatment and diagnosis of cancer |
| 09/15/1994 | WO1994020859A1 Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor |
| 09/15/1994 | WO1994020637A1 Fertility regulation with transforming growth factor beta |
| 09/15/1994 | WO1994020625A1 Method for inducing tumor cell death |
| 09/15/1994 | WO1994020622A1 Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus |
| 09/15/1994 | WO1994020619A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
| 09/15/1994 | WO1994020618A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 09/15/1994 | WO1994020614A1 Allergenic protein and peptides from house dust mite and uses therefor |
| 09/15/1994 | WO1994020538A1 Extraction of cell-bound protein from bordetella |
| 09/15/1994 | WO1994020536A1 Methods, compositions, and kits for diagnosing lyme disease |
| 09/15/1994 | WO1994020523A1 Tumor targeting with l-enantiomeric oligonucleotide conjugates of immunoreagents and of chelated radionuclides |
| 09/15/1994 | WO1994020487A1 Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents |
| 09/15/1994 | WO1994020142A1 Assays and therapeutic methods based on lymphocyte chemoattractants |
| 09/15/1994 | WO1994020141A1 Therapeutic strategies for immunoinfective cluster virus infections |
| 09/15/1994 | WO1994020140A1 COMPOSITONS COMPRISING IgG3 ANTIBODIES |
| 09/15/1994 | WO1994020138A1 Recombinant epstein-barr virus protein and its use in vaccine |
| 09/15/1994 | WO1994020137A1 Production of human papillomavirus capsid protein and virus-like particles |
| 09/15/1994 | WO1994020135A1 Vaccines expressed in plants |
| 09/15/1994 | WO1994020124A1 Method of cancer treatment |
| 09/15/1994 | WO1994020083A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | WO1994020071A1 Water-in-oil fluid vaccinal emulsions containing a metabolizable oil |
| 09/15/1994 | WO1994020070A1 Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
| 09/15/1994 | WO1994020063A2 Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
| 09/15/1994 | WO1994019935A1 Isolation of components of interest from milk |
| 09/15/1994 | WO1994017192A3 Lysosomal targeting of immunogens |
| 09/15/1994 | CA2511085A1 Lo-cd2a antibody and uses thereof for inhibiting t-cell activation and proliferation |
| 09/15/1994 | CA2158040A1 Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
| 09/15/1994 | CA2157902A1 Tumour targeting with l-enantiomeric oligonucleotide conjugates of immunoreagents and of chelated radionuclides |
| 09/15/1994 | CA2157900A1 Therapeutic strategies for immunoinfective cluster virus infections |
| 09/15/1994 | CA2157868A1 Diagnostic kit for a cancer producing hcg or hcg fragments; methods used for the immunotherapy of said cancer |
| 09/15/1994 | CA2157865A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | CA2157863A1 Compositions comprising igg3 antibodies |
| 09/15/1994 | CA2157770A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 09/15/1994 | CA2157402A1 Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents |
| 09/15/1994 | CA2157379A1 Method of cancer treatment |
| 09/15/1994 | CA2157010A1 Method for inducing tumor cell death |
| 09/15/1994 | CA2156719A1 Recombinant epstein-barr virus protein and its use in vaccine |
| 09/15/1994 | CA2156613A1 Fertility regulation with transforming growth factor beta |
| 09/14/1994 | EP0614985A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 09/14/1994 | EP0614984A2 Human anti-TNF antibodies |
| 09/14/1994 | EP0614981A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 09/14/1994 | EP0614979A1 Hog cholera virus vaccine and diagnostic |
| 09/14/1994 | EP0614974A2 Bone - associated transcription control factor-like protein and process for producing the same |
| 09/14/1994 | EP0614973A1 Polypeptide useful in diagnosis of coccidia infection and recombinant-DNA methods for manufacturing same |
| 09/14/1994 | EP0614489A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
| 09/14/1994 | EP0614488A1 Recombinant vaccine against lyme disease |
| 09/14/1994 | EP0614486A1 Targeted delivery of virus vector to mammalian cells |
| 09/14/1994 | EP0614465A1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
| 09/14/1994 | EP0614464A1 Peptides and antibodies for treatment of rheumatoid arthritis |
| 09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 09/14/1994 | EP0614373A1 Oral pharmaceutical composition containing polyethylene glycol immunoglobulin conjugate |
| 09/14/1994 | EP0614371A1 Pasteurella multocida toxoid vaccines |
| 09/14/1994 | EP0614355A1 Antitumor vaccines |
| 09/14/1994 | EP0339040B1 Swine dysentery vaccine |
| 09/14/1994 | CN1091979A Immune serum globulin for intravenous injection and preparing method thereof |
| 09/14/1994 | CN1091978A Use of GM-CSF as a vaccine adjuvant |
| 09/13/1994 | US5346989 Peptides for use in induction of T cell activation against HIV-1 |
| 09/13/1994 | US5346687 Partial reduction of disulfide bonds with stannous compound |
| 09/11/1994 | CA2118642A1 Bone-associated transcription control factor-like protein and process for producing the same |
| 09/07/1994 | EP0613945A2 Tumor suppressor gene merlin and uses thereof |
| 09/07/1994 | EP0613944A2 Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules |
| 09/07/1994 | EP0613500A1 Membrane expression of heterologous genes |
| 09/07/1994 | EP0613498A1 Receptor derivates with binding sites for human rhinoviruses |
| 09/07/1994 | EP0613495A1 Transgenic animals lacking prion proteins |
| 09/07/1994 | EP0613378A1 Induction of protection against viral infection by synergy between viral proteins and viral peptides |